Last updated 25 August 2026 · Originally published 7 June 2019
CBD bioavailability means how much of the CBD you take actually reaches your bloodstream. For CBD that is swallowed, the answer is: not much, and less than you might think. Most of a swallowed dose never gets past the gut and the liver. This matters because the same labelled dose can produce very different blood exposure depending on the formulation, the food you took it with and how it was tested. A 25 mg gummy and a 25 mg trial dose are not automatically equivalent. It is also the reason so many products promise to fix it.
The number everyone quotes, and what it really is
You will see oral CBD bioavailability given everywhere as about 6%, including, until recently, in one of our own articles. That number is an estimate, not a direct measurement. Establishing absolute bioavailability normally means comparing the same drug taken by mouth and given intravenously. When researchers at the University of Nottingham reviewed the human evidence in 2018, they found that no oral CBD study had done that.
The 6% figure is not invented. It was calculated from older human data, and a later analysis judged it plausible for CBD taken on an empty stomach. But it is not a fixed property of every oil, gummy, dose or person. Food and formulation can multiply how much CBD reaches the blood, and the variation between individuals is substantial.
So the honest conclusion is not that oral bioavailability is an unknown number. It is that oral exposure is generally low when fasting, and that no single percentage describes every product and circumstance.
Why so little gets through
CBD dissolves readily in fat but very poorly in water. In the digestive tract, some of it can separate out or stay unavailable for absorption. Much of what does cross the gut wall then travels through the liver, where a substantial proportion is broken down before it reaches the wider circulation. Pharmacologists call this first-pass metabolism. Some CBD may instead enter the lymphatic system, particularly when taken with fat, which is part of why food matters so much.
Everything sold as a way to improve bioavailability is trying to get around one or both of those two problems: get more CBD across the gut wall, or get it into the blood without going through the liver first.
What actually helps: eat something fatty
The single best-supported way to absorb more CBD is to take it with a meal that contains fat. This has been shown repeatedly in people, at both prescription doses and consumer doses. In a University of Minnesota study, eight people with epilepsy took the same purified CBD capsule once after fasting and once after a high-fat breakfast. With the meal, the peak level of CBD in their blood was on average 14 times higher, and overall blood exposure was about four times greater. A 2025 study found an even larger effect with a 70 mg dose of a hemp extract, which is closer to what people actually buy: among 11 participants, a high-fat meal raised the peak blood level 17 times and overall blood exposure almost 10 times.
One caution follows directly. If you take prescription CBD, do not switch from taking it fasted to taking it with a fatty meal without talking to your prescriber. That change can multiply your exposure without changing the prescribed dose.
The catch is in the word “variability”. A fatty meal increases absorption, but different meals have different amounts of fat, so the same dose taken with breakfast one day and dinner the next can produce quite different blood levels. If you take CBD for a reason that matters to you, taking it the same way each time is worth more than any single trick.
Under the tongue: less certain than the label suggests
Almost every CBD oil tells you to hold the drops under your tongue before swallowing. The idea is that CBD absorbs through the lining of the mouth directly into the blood, skipping the liver. That is how the prescription THC–CBD mouth spray is designed to work, and it is a reasonable expectation for an oil. The question is how much of the dose actually gets in that way before you swallow.
The one study to test it directly was small. In a 2023 trial at Loughborough University, eight men took the same hemp oil either as drops under the tongue or in a capsule they swallowed, and their blood levels came out much the same. The study did not reveal a large advantage for the drops, although eight participants and a single dose cannot exclude a smaller one. The fair conclusion is that ordinary CBD oil has not demonstrated the substantial absorption advantage its instructions often imply.
No human study has established a best holding time. Following the product instructions is reasonable, but there is no good evidence that holding ordinary CBD oil under the tongue for longer materially improves absorption.
“Water-soluble” and “nano” CBD
This is where the marketing gets loud. Products described as water-soluble, nano-emulsified, liposomal or “up to five times more bioavailable” are different technologies, but all attempt to keep CBD dispersed and available for absorption in the watery environment of the digestive tract. In small human studies it works. In a 2025 crossover trial of 14 people, a self-emulsifying powder produced 2.3 times the total CBD exposure of oil-based drops. That formulation contained THC as well as CBD, so the result should not be transferred automatically to every product labelled “nano CBD”.
Three things to keep in mind before paying extra. The improvement is measured against one specific formulation under particular conditions. Many comparisons use a fasting reference, and few have tested whether the advantage remains when ordinary CBD oil is taken with a high-fat meal. The formulations differ from each other and a claim on one product does not transfer to another. And more CBD in the blood is only worth having if the CBD is doing something at that level, which for most of the uses people buy it for is not established. A better-absorbed dose of something that does not work is still something that does not work.
There is also a quieter point. If a product really does deliver several times more CBD to the blood, it is closer to a medicine and further from a supplement, and the same caution about liver effects at higher exposure applies.
Other routes
Inhaling CBD gets it into the blood quickly and avoids first-pass metabolism. It is also the only route with a published absolute-bioavailability estimate in humans: an average of 31%, ranging from 11% to 45%, in a study of just five people. It comes with the separate risks of inhaling anything. Skin creams mostly stay in the skin, which is fine if the skin is where you want it, and patches designed to push CBD through into the blood are a different product again. We compare the options in our guide to ways of taking CBD.
What this means for the dose on the label
Two things follow. First, the amount you swallow is not the amount that reaches your bloodstream, and the gap is large and unpredictable. What does get in then lingers: CBD is stored in body fat and clears slowly, which is why it can stay in your system for days after a single dose. Second, when a clinical trial reports a result at a given dose, that result was produced under conditions — the formulation, whether it was taken with food, the timing — that your bottle does not reproduce. That is a reason to be cautious about what a trial promises for a retail product, not a reason to take more of the retail product to compensate. We set out why in the dosage article.
If you want the best CBD bioavailability from a swallowed dose, take it with food that contains fat, take it the same way each time, and check the certificate of analysis so you know the label figure was accurate to begin with. Beyond that, be sceptical of products that lead with a bioavailability percentage unless the company has tested that specific formulation against a clearly identified comparison under controlled conditions.
Nothing in this article is medical advice. If you take prescription medication, speak to a doctor or pharmacist before using CBD, as it can interact with a range of common drugs.
